ES516840A0 - Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina. - Google Patents

Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina.

Info

Publication number
ES516840A0
ES516840A0 ES516840A ES516840A ES516840A0 ES 516840 A0 ES516840 A0 ES 516840A0 ES 516840 A ES516840 A ES 516840A ES 516840 A ES516840 A ES 516840A ES 516840 A0 ES516840 A0 ES 516840A0
Authority
ES
Spain
Prior art keywords
cyclodextrin
procedure
water
poorly soluble
inclusion complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516840A
Other languages
English (en)
Spanish (es)
Other versions
ES8308571A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of ES516840A0 publication Critical patent/ES516840A0/es
Publication of ES8308571A1 publication Critical patent/ES8308571A1/es
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
ES516840A 1981-10-27 1982-10-26 Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina. Expired ES8308571A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU813147A HU190356B (en) 1981-10-27 1981-10-27 Process for preparing steroid-gamma-cyclodextrin inclusion complexes with high water-solubility

Publications (2)

Publication Number Publication Date
ES516840A0 true ES516840A0 (es) 1983-09-16
ES8308571A1 ES8308571A1 (es) 1983-09-16

Family

ID=10962794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES516840A Expired ES8308571A1 (es) 1981-10-27 1982-10-26 Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina.

Country Status (12)

Country Link
JP (1) JPS5883699A (de)
BE (1) BE894825A (de)
DD (1) DD208549A5 (de)
DE (1) DE3238800A1 (de)
DK (1) DK474782A (de)
ES (1) ES8308571A1 (de)
FR (1) FR2515187A1 (de)
GB (1) GB2109381A (de)
HU (1) HU190356B (de)
IT (1) IT1191049B (de)
NL (1) NL8204122A (de)
SE (1) SE8206055L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196230B (en) * 1983-12-29 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect
GB2162529B (en) * 1984-06-08 1988-03-02 Nitrokemia Ipartelepek B-cyclodextrin complex of benzene sulphonyl urea derivatives
US5223295A (en) * 1988-01-22 1993-06-29 Asterol International Process for the elimination of steroid compounds contained in substance of biological origin
US5229370A (en) * 1988-08-15 1993-07-20 Ammeraal Robert N Water soluble branched beta cyclodextrin steroid complex
EP0381747A4 (en) * 1988-08-15 1991-09-11 American Maize-Products Company Water soluble branched beta cyclodextrin steroid complex
CA2087452A1 (en) * 1991-05-20 1992-11-21 Toshiro Tsuda Steriod compound combined with polysaccharide
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US20040048830A1 (en) * 2000-11-02 2004-03-11 Mingqiang Zhang Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
WO2002049674A1 (en) * 2000-12-20 2002-06-27 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes
EP1216712A1 (de) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Einschlusskomplexe von Drospirenone und Cyclodextrinen
EP1216713A1 (de) 2000-12-20 2002-06-26 Schering Aktiengesellschaft Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
WO2013135248A2 (en) * 2012-03-13 2013-09-19 Amphidex A/S Production of stabilized channel type cyclodextrin crystals

Also Published As

Publication number Publication date
IT1191049B (it) 1988-02-24
NL8204122A (nl) 1983-05-16
GB2109381A (en) 1983-06-02
ES8308571A1 (es) 1983-09-16
BE894825A (fr) 1983-02-14
IT8223942A0 (it) 1982-10-26
HU190356B (en) 1986-08-28
SE8206055D0 (sv) 1982-10-25
DE3238800A1 (de) 1983-05-05
FR2515187A1 (fr) 1983-04-29
DK474782A (da) 1983-04-28
SE8206055L (sv) 1983-04-28
DD208549A5 (de) 1984-04-04
JPS5883699A (ja) 1983-05-19

Similar Documents

Publication Publication Date Title
ES517764A0 (es) Procedimiento de preparacion de nuevos derivados esteroides sustituidos en 11b.
JPS5567305A (en) Antifrothing agent and use for its water system antifrothing
JPS5570308A (en) Water antifrothing agent* its preparation and its use
SE7811853L (sv) Isertagbar rullstol
NL7704035A (nl) Verbetering van de werkwijzen ter bereiding van door fotopolymerisatie in water oplosbare acryl- polymeren.
DK158391C (da) Afloebsanlaeg
BR8200424A (pt) Cateter para diagnostico para fazer cistometrograma
ES516840A0 (es) Procedimiento para preparar complejos de inclusion de esteroides pobremente solubles en agua con -ciclodextrina.
AR222972A1 (es) Procedimiento de preparacion de un preparado enzimatico insoluble en agua
NL7903775A (nl) Werkwijze ter bereiding van in water onoplosbaar carboxymethylcellulose.
MX4350E (es) Procedimiento para la preparacion de compuestos monoazoicos insolubles en agua
ES518189A0 (es) Procedimiento para preparar nuevos derivados de encefalina.
BR7802684A (pt) Poliester termofixavel soluvel em agua
NL7900264A (nl) 4-pyridon-3-carbonzuurderivaten alsmede de bereiding ervan.
MX144552A (es) Procedimiento para la preparacion de colorantes monoazo solubles en agua
ES511058A0 (es) Procedimiento para preparar nuevos derivados de fenoxibencilo.
MX155941A (es) Procedimiento para preparar colorantes disazoicos solubles en agua
DD135016A1 (de) Streifenleitungsrichtungskoppler geringer koppeldaempfung
SE7903712L (sv) Urinextraktionssystem
MX160240A (es) Procedimiento para recuperar molibdeno disuelto
GB2025394B (en) Benzoylphenoxyalkanoic acid derivatives their use and preparation
IT1163673B (it) Sistema di ancoraggio
MY8500351A (en) Pyridine derivatives as anti-inflammatory and immuno-regulatory agents
JPS5499196A (en) Swellable water retention agent and its preparation
ES516012A0 (es) Procedimiento para preparar n-alcoxisulfenicarbamatos.